FCAP vs TMO · P/E 12, $211.2M cap vs P/E 24, rev $44.56B
First Capital Inc (FCAP) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
First Capital Inc (FCAP) is a banks - regional company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
FCAP does not have a complete income-statement cache yet.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
FCAP currently screens at market cap $211.2M and trailing P/E 12.1. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the FCAP and TMO stock pages for the full models.
Not investment advice.